Provided by Tiger Fintech (Singapore) Pte. Ltd.

Pfizer

23.49
+0.20000.86%
Post-market: 23.530.0400+0.17%19:59 EDT
Volume:51.33M
Turnover:1.20B
Market Cap:133.55B
PE:16.98
High:23.52
Open:23.30
Low:23.11
Close:23.29
Loading ...

MEDIA-Pfizer CEO attending $25 million fundraiser at Trump's golf club -CBS News

Reuters
·
Yesterday

Mixed options sentiment in Pfizer with shares up 0.88%

TIPRANKS
·
Yesterday

Pfizer’s New Study on PF-07934040: A Potential Game-Changer in Cancer Treatment?

TIPRANKS
·
Yesterday

Pfizer’s Ongoing Safety Study of BNT162b2 in Korea: Key Insights for Investors

TIPRANKS
·
Yesterday

3 Dividend Healthcare Stocks to Buy Hand Over Fist Before They Double

Motley Fool
·
01 Aug

Moderna Wins UK Patent Dispute Against Pfizer, BioNTech

MT Newswires Live
·
01 Aug

Pfizer, BioNTech Lose UK Court Appeal to Invalidate BioNTech Patent Over Mrna Technology in Covid-19 Vaccines

THOMSON REUTERS
·
01 Aug

Pantera Lithium Announces General Meeting for Shareholders

TIPRANKS
·
01 Aug

Pfizer Inc. Stock Underperforms Thursday When Compared To Competitors

Dow Jones
·
01 Aug

Trump Threatens Pharma Giants over ‘Abusive’ Drug Prices

TIPRANKS
·
01 Aug

Pfizer’s Phase 3 Study on Elranatamab vs. Lenalidomide: A Potential Game-Changer in Multiple Myeloma Treatment

TIPRANKS
·
01 Aug

Pfizer’s Abrocitinib Study: A New Hope for Atopic Dermatitis Treatment

TIPRANKS
·
01 Aug

Pfizer and Astellas Advance Prostate Cancer Study with Promising Drug Combo

TIPRANKS
·
01 Aug

Should You Buy Pfizer (PFE) Stock Before August 5? Here's What History Says

Motley Fool
·
31 Jul

Bristol Myers posts better-than-expected second quarter results on strength of top sellers

Reuters
·
31 Jul

UPS Stock Joins 7% Yielders in S&P 500. Here's Who Else Is in the Club. -- Barrons.com

Dow Jones
·
31 Jul

Pfizer’s New Study on Abrocitinib: A Potential Game-Changer for Pediatric Eczema

TIPRANKS
·
31 Jul

Pfizer’s New Phase 1 Study: A Potential Breakthrough in Cancer Treatment

TIPRANKS
·
30 Jul

BRIEF-FDA To Discontinue Pfizer's Mensest tablet

Reuters
·
29 Jul

FDA: Discontinuation of Manufacture of Pfizer's Menest, Tablet, .3 Mg & Menest, Tablet, .625 Mg- Website

THOMSON REUTERS
·
29 Jul